Johnson & Johnson published a piece in the Financial Times exploring how policies focused primarily on short-term cost containment affect patient access, weaken incentives for innovation and investment, and undermine Europe's competitiveness.
Published
Signal category
Research & Knowledge
Quote
“Our latest piece in the Financial Times explores how policies focused primarily on short-term cost containment can affect patient access, weaken incentives for innovation and investment, and ultimately undermine Europe’s competitiveness.”
— Emmanuelle Stoetzel|Johnson & Johnson team
Company
- Industry
- Hospitals and Health Care
- Location
- New Brunswick, US
- Company size
- 135,433 employees
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines